Proactive infliximab is more effective than vedolizumab in inducing fecal calprotectin remission in inflammatory bowel disease. Fernandes SR, Rodrigues IC, Serrazina J, Botto IA, et al. Scand J Gastroenterol 2022 May 22:1-7. doi: 10.1080/00365521.2022.2076567.

Read + Share

Amedeo Smart

Independent Medical Education

Fernandes SR, Rodrigues IC, Serrazina J, Botto IA, et al. Proactive infliximab is more effective than vedolizumab in inducing fecal calprotectin remission in inflammatory bowel disease. Scand J Gastroenterol 2022 May 22:1-7. doi: 10.1080/00365521.2022.2076567.
PMID: 35599574